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OBJECTIVE: To assess the prevalence of urinary incontinence and associated vaginal squeeze pressure in primiparous
women with and without previous gestational diabetes mellitus two years post-cesarean delivery.
METHODS: Primiparous women who delivered by cesarean two years previously were interviewed about the
delivery and the occurrence of incontinence. Incontinence was reported by the women and vaginal pressure
evaluated by a Perina perineometer. Sixty-three women with gestational diabetes and 98 women without the
disease were screened for incontinence and vaginal pressure. Multiple logistic regression models were used to
evaluate the independent effects of gestational diabetes.
RESULTS: The prevalence of gestational incontinence was higher among women with gestational diabetes during
their pregnancies (50.8% vs. 31.6%) and two years after a cesarean (44.8% vs. 18.4%). Decreased vaginal pressure
was also significantly higher among women with gestational diabetes (53.9% vs. 37.8%). Maternal weight gain and
newborn weight were risk factors for decreased vaginal pressure. Maternal age, gestational incontinence and
decreased vaginal pressure were risk factors for incontinence two years after a cesarean. In a multivariate logistic
model, gestational diabetes was an independent risk factor for gestational incontinence.
CONCLUSIONS: The prevalence of incontinence and decreased vaginal pressure two years post-cesarean were
elevated among women with gestational diabetes compared to women who were normoglycemic during
pregnancy. We confirmed an association between gestational diabetes mellitus and a subsequent decrease of
vaginal pressure two years post-cesarean. These results may warrant more comprehensive prospective and
translational studies.
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INTRODUCTION
Diabetes increases the risk of urinary incontinence (UI) 2.5
fold,
1-3 although the mechanisms by which type 2 Diabetes
Mellitus (type 2 DM) contributes to UI development and
severity are not well understood.
4 Diabetes is associated
with an impairment of muscle strength and physical
function.
5 There is a temporal relationship between the
time of diabetes diagnosis and subsequent development of
muscle weakness and other related complications, such as
diabetic amyotrophy.
6
Gestational diabetes mellitus (GDM) is a metabolic
disorder that is considered to be similar to type 2 DM. In
GDM, pregnancy acts as a ‘‘stress factor,’’ revealing an
individual’s tendency to become diabetic.
7 GDM is asso-
ciated with macrosomia, shoulder dystocia, cesarean section
(CS), intrauterine fetal growth alterations and perinatal
mortality.
8,9 Fetal macrosomia increases the risk for the
development of GDM-independent UI,
10 and one of the
confounding variables in the development of UI is delivery
method. Chawla et al. demonstrated an association between
multiparity and vaginal delivery with an increased risk for
UI and decreased vaginal squeeze pressure (VSP).
11
Diabetes and vaginal deliveries are the most significant
risk factors implicated in the incidence of UI,
3 although little
is known about whether GDM and the length of time
elapsed after GDM are connected to a loss of bladder
control. Kim et al. demonstrated that UI is common among
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1341women with a history of GDM but does not appear to be
associated with physical activity level or body mass index
(BMI).
12 The Kim study neither quantified pelvic floor
muscle function nor controlled for the mode and number of
deliveries and the time from delivery to evaluation. More
detailed information would allow for quantification of UI
risk of UI within the population affected by GDM, such as
women who will be receiving a CS for their current
pregnancy or those who have received a CS during previous
pregnancies. The aim of this study was to evaluate the
prevalence of UI and VSP two years post-CS in primiparous
women with or without previous Gestational diabetes
mellitus (pGDM) and to investigate the association between
UI, VSP and pGDM.
MATERIALS AND METHODS
The Institutional Review Board of Botucatu Medical
School, UNESP-Univ Estadual Paulista, Sa ˜o Paulo, Brazil,
granted approval for this prospective study, and all subjects
gave informed written consent.
This study consisted of a cross-sectional survey con-
ducted at the Department of Gynecology and Obstetrics
General Hospital, a university hospital. All women who
participated in this study, when pregnant, were patients of
this hospital and were routinely screened for GDM at 24-28
weeks of gestation. The cutoff values for the diagnosis of
GDM were those proposed by Carpenter & Coustan,
13 i.e.,
95 mg/dl, 180 mg/dl, 155 mg/dl, and 140 mg/dl, at fast-
ing, one, two and three hours after oral glucose load,
respectively.
All women in this perinatal database who had delivered
two years earlier (between January 1
st, 2004, and September
30
th, 2004), a total of 529 subjects, were eligible for inclusion
in the study. They were contacted by phone and invited to
participate. The women answered questions based on the
Questionnaire for Urinary Incontinence Diagnosis
14 and the
International Consultation on Incontinence Questionnaire -
Short Form (ICIQ-SF) translated into Portuguese and
validated with Brazilian female patients complaining of
urinary incontinence.
15 The patients were questioned about
the following aspects of pregnancy and childbirth: maternal
weight gain, the newborn weight, if they entered partum
labor, postpartum complications, involuntary urine loss (for
efforts such as coughing, sneezing, laughing, catching
weight, squatting, walking and/or involuntary urine lost
when feeling a strong urge to urinate, contact with water,
sound of running water or if exposed to low temperatures)
during pregnancy and postpartum.
Of the 529 possible participants, 161 eligible primiparous
women with singleton pregnancies delivered by CS who
met the inclusion criteria were identified. An overview of
the study design is outlined in Figure 1. Power analysis was
performed based on a positive diagnosis of hyperglycemia
during pregnancy with a type I error of 0.05 and a type II
error of 0.20. The analysis indicated that the minimum
number of patients enrolled in each group should be 62.
A trained physician who was blinded to the results of the
oral glucose tolerance test obtained obstetric and maternal
data relating to the index pregnancy from the hospital
records. Demographic data collected included maternal age,
gestational age at delivery, body mass index (BMI-weight in
kilograms divided by height in meters squared), weight
gain during pregnancy, delivery method and birth weight.
Two years postpartum, all patients were interviewed
regarding their UI symptoms and the prevalence of these
symptoms before, during and two years after the index
pregnancy. The same author conducted all interviews. UI
was as defined by Abrams et al.
12 as an involuntary leakage
of urine. After the interview, bidigital palpation and
perineometry were performed. First, vaginal bidigital
palpation was performed with the woman’s knees semi-
flexed. The subjects were asked to squeeze the vagina three
times.
16 While the subjects were in the same position, a
vaginal latex sensor called a Perina perineometer was
employed to measure the strength of the squeezes (Quark,
Sa ˜o Paulo, Brazil). Based on a previous study of nulliparous
women, perineometric values higher than 33.6 mmHg were
considered to be normal. The perineometer used was not a
validated device. It was selected based on the results of a
pilot study of Barbosa.
17
Statistical analyses were performed using the PASW
Statistics v.17.0.2 and SAS 9.03 software programs. The
statistical significance level was set at p,0.05. Categorical
variables were analyzed using descriptive procedures and
are expressed as percentages. The impacts of maternal age,
gestational age at delivery, BMI, weight gain during
pregnancy, birth weight, GDM, VSP and UI two years
postpartum were evaluated in univariate analyses. Multiple
logistic regression models were then used to evaluate the
independent effects of GDM and maternal age on gesta-
tional UI after controlling for other significant factors.
Odds ratios were computed to express the magnitude
of the association between UI, VSP and GDM with 95%
Figure 1 - Overview of the study design.
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adjusted odds ratios (OR) and estimates of 95% confidence
intervals (95% CI) were based on the Mantel-Haenszel x
2
test. The adjusted odds ratios were calculated to express the
magnitude of the association between prior GDM and UI/
VSP and were controlled for other confounding variables.
For logistic regression analyses, UI and VSP were used as
the response variables.
RESULTS
Clinical data for pGDM patients and control subjects at
the time of pregnancy and two years after CS are shown in
Table 1. Among the 161 patients enrolled, 63 (39.1%) had
pGDM and 98 (60.9%) did not have pGDM. The length of
time since the index pregnancy was similar for both groups
(25.8¡3.2 months for pGDM and 24.8¡2.1 months for
controls). The overall prevalence of gestational UI and two-
year postpartum UI was significantly higher among women
with pGDM (50.8% and 44.4%, respectively) than among
normoglycemic pregnant women (31.6% and 18.4%, respec-
tively, p,0.01). In addition, decreased VSP was more
frequently found in women with pGDM two years after
receipt of CS than in the control group (53.9% and 31.6%,
respectively, p=0.04). Subject skin color, black, was homo-
geneous for both groups (14.2% for pGDM and 13.3% for
controls, p=0.08).
Women with pGDM were older (29.3¡6.1 years vs.
25.4¡3.2 years) and experienced greater weight gain during
pregnancy (17.3¡6.1 vs. 14.6¡4.1) compared to controls.
Women with pGDM were more likely to have a lower
gestational age at delivery (38.7¡0.8 weeks vs. 39.7¡1.3
weeks) and a higher newborn weight (3546.2¡440.6 grams
vs. 3143.1¡472.9 grams, Table 1).
In the multivariate logistic model, newborn weight (OR
1.002; 95% CI: 1.001-1.002) and maternal weight gain (OR
1.295; 95% CI: 1.176-1.425) was associated with a decrease in
VSP in cases of pGDM (Table 2). We constructed a separate
model for two-year post-CS UI in women with pGDM and
found that maternal age (OR 1.181; 95% CI: 1.022-1.365),
gestational UI (OR 4.992; 95% CI: 1.383-18.023) and a
decrease in VSP incidence (OR 20.416; 95% CI: 3.548-
117.479) were associated factors (Table 3). In the multi-
variate logistic models, pGDM was an independent risk
factor (OR 2.26; 95% CI: 1.116-4.579) for gestational UI
(Table 4).
DISCUSSION
GDM is considered to be an early stage in the natural
history of type 2 DM. Women with prior GDM are at a
higher risk of developing type 2 DM or some degree of
glucose intolerance two to twelve years after the index
pregnancy.
18 In the present study, the presence of pGDM
increased the incidence rate of UI not only during
pregnancy but also after a CS. Approximately half of the
women with pGDM reported having UI during their
pregnancy (50.8%) and two years post-CS (44.4%). These
results confirm an association between pGDM, UI and
decreased VSP.
It is interesting to note that blood glucose levels do not
become sufficiently elevated to cause osmotic diuresis or
increase involuntary urinary loss during pregnancy.
9 A
history of at least one vaginal delivery, family history of
prolapsed and a macrosomatic fetus have been shown to be
independent risk factors for urinary incontinence and
prolapse.
10 The greater weight gain for fetuses in women
with GDM, resulting in increased intra-abdominal pressure,
could also contribute to UI. It is important to take into
consideration that delivery at an earlier gestational age could
decrease the rate of UI perinatal complications because of the
smaller expected size of prematurely delivered newborns.
19
An increased prevalence of UI among women with
diabetes has been reported in cross-sectional analyses.
20 In
the NHANES 2001-2002 study, one in three women with
impaired fasting glucose or diabetes reported weekly or
more frequent UI.
21 However, no previous studies have
examined whether women with pGDM also have an
increased prevalence of UI two years after a CS. The results
presented here suggest that the cesarean delivery route does
not protect against UI two years after delivery in women
with pGDM. Instead, our results suggest that the complica-
tions of pGDM, including possible microvascular disease,
seem to be a more relevant factor than the mode of delivery.
The potential mechanisms by which diabetes causes
incontinence include microvascular damage to the innerva-
tion of the bladder and urethral sphincter, detrusor muscle
dysfunction, sphincter dysfunction, overactive bladder,
urinary retention and elevated post-void residual urine
volume, which contributes to overflow incontinence, chro-
nic bacterial colonization, urinary tract infections and hy-
perglycemia.
22 Moreover, the microvascular complications
Table 1 - Characteristics of women with and without GDM during their pregnancies and two years post- cesarean
section.
Control group
n=98
GDM
n=63
n (%) m ¡ sd n (%) m ¡ sd p-value
Maternal age two years post-cesarean — 25.4¡3.2 — 29.3¡6.15 0.0001
Gestational age at delivery (w) — 39.7¡1.3 — 38.7¡0.8 0.0001
Weight gain during index gestation (kg) — 14.6¡4.1 — 17.3¡6.1 0.0003
Newborn weight (g) — 3143.1¡472.9 — 3546.2¡440.6 0.0001
Length of time since index pregnancy (y) — 24.8¡2.1 — 25.0¡0.8 0.4621
BMI (kg/m
2)— 25.5¡4.3 — 25.8¡3.2 0.5748
Decresead of VSP 37 (37.8) — 34 (53.9) — 0.0431
Pre-gestational UI 7 (7.1) — 10 (15.9) — 0.0785
Gestational UI 31 (31.6) — 32 (50.8) — 0.0151
UI two years postpartum 18 (18.4) — 28 (44.4) — 0.0004
Black skin color 13 (13,3) — 9 (14,2) — 0.0823
CLINICS 2011;66(8):1341-1345 Incontinence and vaginal squeeze pressure following gestational diabetes
Barbosa AMP et al.
1343associated with type 2 DM may damage the innervation of
the bladder and/or alter detrusor muscle function.
23
The present study has also demonstrated that patients
with pGDM have a larger VSP decrease (50.8%) two years
post-CS than the controls (37.8%). The results of a study by
Casey et al. indicated that the increased prevalence of
decreased VSP could be related to high rates of obesity and
macrosomia pregnancies. Our results partially confirm these
results, as there remains an association between newborn
weight and VSP (OR 1.295 CI95% 1.176-1.425). Diabetes is
associated with impaired muscle strength and physical
function and may provide a link between the metabolic and
mechanical functions of muscles.
5 Motor dysfunction is
considered an end-stage manifestation of severe polyneuro-
pathy with an annual decline in muscle strength of
approximately 3%, although motor function in type 2 DM
is still unknown.
24 Muscle weakness is considered a
progressive late complication in diabetic distal symmetric
polyneuropathy and has been associated with atrophy of
striated muscle, probably because of insufficient re-innerva-
tion.
24 Almost all muscle weakness in diabetes relates to
distal weakness and the atrophy of the muscles of the lower
leg and foot.
24,25
In a multivariate logistic model, maternal weight gain
during pregnancy and newborn weight were associated
with decreased VSP, and GDM itself was not a significant
risk factor (Table 2). This finding suggests that decreased
VSP two years post-CS may be a consequence of either
maternal or perinatal adverse effects related to GDM,
maternal weight gain during pregnancy and newborn
weight. GDM has previously been associated with both an
increased risk of fetal and neonatal macrosomia
26 and high
maternal BMI.
27
A higher BMI could theoretically enhance abdominal
pressure, thereby increasing bladder pressure and urethral
mobility, which could lead to the association seen between
BMI and UI.
22 Excessive body weight could also affect
bladder pressure and could also be a factor in the
development of UI.
27 Therefore, decreased VSP two years
post-CS in women with pGDM may be a consequence of the
interaction between pregnancy and GDM. Our findings that
advanced maternal age, UI during pregnancy and decreased
VSP are risk factors for UI suggest that UI may also be an
indirect consequence of GDM.
We are aware that our study sample and findings may be
biased by the facts that the incontinence outcomes were self-
reported and that patients were from a prenatal care service
with routine screening for GDM. Patients who are sympto-
matic may be more willing to undergo an evaluation and
receive treatment. However, our findings are in agreement
with a previous study.
12 Our data confirm the interaction
between pGDM, UI and decreased VSP. Our data also
extend this association to women who delivered by CS.
These observations strongly suggest that further more
comprehensive, prospective controlled and translational
studies are warranted.
CONCLUSIONS
The prevalence of UI and decreased VSP two years post-
CS were elevated among women with pGDM compared to
normoglycemic controls during pregnancy. We confirmed
an association between pGDM and a subsequent VSP
decrease two years post-CS. These results may warrant the
beginning of more comprehensive prospective and transla-
tional studies.
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